You are here: Home > For Researchers > Projects > Genetic Network Inference - Development of a generic methodology for genetic network inference

Genetic Network Inference - Development of a generic methodology for genetic network inference

From 10-01-2001 to 30-09-2006

Description

Bioinformatics research has focused mainly on the application of mathematical methods on high-dimensional data generated by high-throughput molecular and biological techniques. Part of those tools lack the necessary biological relevance. The future of bioinformatics lies in the design of more biology oriented algorithms. This interdiscplinary research project can be situated in this perspective. Concretely, the selection, implementation and optimization of existing mathematical methods for the identification and modeling of regulatory interactions is studied. Thanks to the accomplishments in high-throughput screening it is now possible to measure simultaneously the expression level of a large set of genes. This flood of data has to be processed with the right datamining and modeling techniques. Genetic network inference is a great challenge both from a biological and systems identification viewpoint. The development of a mathematical framework for inference implies robust preprocessing, optimized feature extraction, selection of the most appropriate model class and training procedure, and interpretation of the results. SCD will profit from the finetuning and optimization of existing methods. From a biological point of view, genetic network inference forms the basis of fundamental and applied research. Since we like to develop a generic method to model regulatory networks in procaryotes and eucaryotes, we opt to study the glycolyzation pathway in yeast and the Type III secretion system (TTSS) in Salmonella thypimurium.

Team

Financing

Funding: KU Leuven - Internal Funding KU Leuven

Program/Grant Type: BOF-Research - BOF Research Programmes

Events

2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery


3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery


12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers


More events

News

STADIUS Alumni Herman Verrelst – new CEO of Biocartis

08 June 2017

Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.


Supporting healthcare policymaking via machine learning – batteries included!

29 May 2017

STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.


Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"

10 February 2017

Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?


Joos Vandewalle is nieuwe voorzitter KVAB

09 October 2016

Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.


More news

Logo STADIUS